In last trading session, Forte Biosciences Inc (NASDAQ:FBRX) saw 0.35 million shares changing hands with its beta currently measuring 2.91. Company’s recent per share price level of $12.25 trading at $0.84 or 7.36% at ring of the bell on the day assigns it a market valuation of $149.62M. That closing price of FBRX’s stock is at a discount of -134.12% from its 52-week high price of $28.68 and is indicating a premium of 66.45% from its 52-week low price of $4.11. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.31 million shares which gives us an average trading volume of 78.48K if we extend that period to 3-months.

For Forte Biosciences Inc (FBRX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

Forte Biosciences Inc (NASDAQ:FBRX) trade information

Upright in the green during last session for gaining 7.36%, in the last five days FBRX remained trading in the red while hitting it’s week-highest on Monday, 06/23/25 when the stock touched $12.25 price level, adding 37.6% to its value on the day. Forte Biosciences Inc’s shares saw a change of 6.52% in year-to-date performance and have moved -16.44% in past 5-day. Forte Biosciences Inc (NASDAQ:FBRX) showed a performance of 26.68% in past 30-days. Number of shares sold short was 0.17 million shares which calculate 2.72 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 24.08% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 61.77% while estimates for its earnings growth in next 5 years are of 41.96%.

Forte Biosciences Inc (NASDAQ:FBRX)’s Major holders

Insiders are in possession of 9.35% of company’s total shares while institution are holding 80.32 percent of that, with stock having share float percentage of 88.60%. Investors also watch the number of corporate investors in a company very closely, which is 80.32% institutions for Forte Biosciences Inc that are currently holding shares of the company. TYBOURNE CAPITAL MANAGEMENT (HK) LTD is the top institutional holder at FBRX for having 3.62 million shares of worth $1.95 million. And as of 2024-06-30, it was holding 7.8653 of the company’s outstanding shares.

The second largest institutional holder is PERCEPTIVE ADVISORS LLC, which was holding about 3.27 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.0858 of outstanding shares, having a total worth of $1.75 million.